4/A//SEC Filing
TIDMARSH GEORGE F 4/A
Accession 0001209191-22-008025
CIK 0001810560other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:24 PM ET
Size
8.9 KB
Accession
0001209191-22-008025
Insider Transaction Report
Form 4/AAmended
TIDMARSH GEORGE F
Director
Transactions
- Purchase
Common Stock
2022-02-04$2.31/sh+7,900$18,256→ 1,481,235 total(indirect: By Trust) - Purchase
Common Stock
2022-02-07$2.61/sh+42,100$109,780→ 1,523,335 total(indirect: By Trust) - Purchase
Common Stock
2022-02-04$2.45/sh+2,000$4,900→ 416,156 total
Footnotes (3)
- [F1]Shares are held by George Tidmarsh, Trustee George Francis Tidmarsh 2021 Irrevocable Trust with respect to which George Tidmarsh is a trustee.
- [F2]Represents the weighted-average price at which shares were purchased within a range between $2.50 and $2.6817. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F3]The original Form 4, filed on February 8, 2022, is being amended by this Form 4 amendment to include shares purchased directly that were inadvertently omitted in the original filing.
Documents
Issuer
REVELATION BIOSCIENCES, INC.
CIK 0001810560
Entity typeother
Related Parties
1- filerCIK 0001287235
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 4:24 PM ET
- Size
- 8.9 KB